MoneyWorks4Me

Transgene Biotek - Quaterly Results

14 Feb 2026 Evaluate
Net sales declined -28.57%  to  Rs. 0.55 million from Rs. 0.77 millions.The Net Loss for the quarter ended December 2025 is Rs. -3.74 millions as compared to Net Loss of Rs. -0.89 millions of corresponding quarter ended December 2024 Operating profit Margin for the quarter ended December 2025 further decreased to -0.50% as compared to -0.49% of corresponding quarter ended December 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 0.55 0.77 -28.57 1.58 1.84 -14.13 2.61 2.35 11.06
Other Income 0.00 0.44 0.00 0.00 7.40 0.00 7.84 1.83 328.42
PBIDT -0.50 -0.49 2.04 -2.62 1.58 -265.82 -3.40 -4.34 -21.66
Interest 2.74 0.17 1511.76 7.84 0.51 1437.25 2.43 1.29 88.37
PBDT -3.24 -0.66 390.91 -10.46 1.07 -1077.57 -5.83 -5.63 3.55
Depreciation 0.50 0.23 117.39 1.50 0.69 117.39 0.93 0.92 1.09
PBT -3.74 -0.89 320.22 -11.96 0.38 -3247.37 -6.76 -6.55 3.21
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -3.74 -0.89 320.22 -11.96 0.38 -3247.37 -6.76 -6.55 3.21
Equity 757.70 757.70 0.00 757.70 757.70 0.00 757.70 757.70 0.00
PBIDTM(%) -90.91 -63.64 42.86 -165.82 85.87 -293.11 -130.27 -184.68 -29.46
Peers
Company Name CMP
Sagility 45.15
Knowledge RealtyTrt. 113.28
Prime Focus 310.60
Indegene 578.05
Syngene Internatl. 382.65
View more..